Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597)

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Teoh, Narci C ^a   Ajamieh, Hussam ^a   Wong, Heng Jian ^a   Croft, Kevin ^b   Mori, Trevor ^b   Allison, Anthony C ^c   Farrell, Geoffrey C ^a  

^a The Australian National University   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c Alavita Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CYCLOOXYGENASE 2; DIANEXIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; ISOPROSTANE DERIVATIVE; JANUS KINASE; LIPOCORTIN 5; PADGEM PROTEIN; PHOSPHATIDYLSERINE; PROTEIN KINASE C DELTA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL DAMAGE; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; ENDOCYTOSIS; ENDOTHELIUM CELL; ENZYME ACTIVATION; HEPATIC ISCHEMIA REPERFUSION INJURY; IN VITRO STUDY; INTRACELLULAR SIGNALING; LIPID ANALYSIS; LIVER CELL; LIVER DISEASE; LIVER PROTECTION; MALE; MEMBRANE BIOLOGY; MEMBRANE MICROPARTICLE; MICROPARTICLE FORMATION; MICROPARTICLE RELEASE; MITOCHONDRIAL MEMBRANE PERMEABILITY TRANSITION; MOLECULAR DYNAMICS; MOUSE; NATURAL KILLER T CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PATHOGENESIS; PROTEIN CONTENT; PROTEIN EXPRESSION; REPERFUSION INJURY; SINUSOIDAL ENDOTHELIAL CELL; THROMBOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; CELL MEMBRANE PERMEABILITY; CELL MOTION; CHEMISTRY; DRUG EFFECTS; LIVER; METABOLISM; MICROCIRCULATION; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; THROMBOCYTE;

ANIMALS; ANNEXIN A5; BLOOD PLATELETS; CELL MEMBRANE PERMEABILITY; CELL MOVEMENT; CELL-DERIVED MICROPARTICLES; E-SELECTIN; ENDOTHELIAL CELLS; HEPATOCYTES; INTERCELLULAR ADHESION MOLECULE-1; LIVER; MALE; MICE, INBRED C57BL; MICROCIRCULATION; NEUTROPHILS; NF-KAPPA B; OXIDATIVE STRESS; P-SELECTIN; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84907222544     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104376     Document Type: Article

References (33)

1. Jaeschke H, Woolbright BL (2012) Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species. Transplant Rev 26:103-114.
2. Teoh N, Farrell G (2003) Hepatic ischaemia reperfusion injury. Pathogenic mechanisms and basis for protection. J Gastroenterol Hepatol 18:891-902.
3. Jaeschke H, Farhood A (2002) Kupffer cell activation after no-flow ischemia versus haemorrhagic shock. Free Rad Bio Med 33:210-219.
4. Samarasinghe D, Farrell GC (2000) Role of oxidative stress in hypoxia-reoxygenation injury to cultured rat hepatic sinusoidal endothelial cells. Hepatology 31:160-165.
5. Vollmar B, Menger MD (2009) The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev 89:1269-1339.
6. Vollmar B, Glasz J, Menger MD, Messmer K (1995) Leukocytes contribute to hepatic ischemia repefusion injury via ICAM-1 mediated venular adherence. Surgery 117:195-200.
7. Qian T, Nieminen AL, Herman B (1997) Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes. Am J Physiol 273:C1783-1792.
8. Teoh N, Field J, Sutton J, Farrell G (2004) Dual role of tumor necrosis factor-a in hepatic ischemia reperfusion injury: studies in TNF-α knockout mice. Hepatology 39:412-421.
9. Esch JS, Jurk K, Knoefel WT, Roeder G, Voss H, et al (2010) Platelet activation and increased tissue factor expression on monocytes in reperfusion injury following orthotopic liver transplantation. Platelets 21:348-359.
10. Teoh N, Ito Y, Field J, McCuskey M, McCuskey R, et al (2007) Diannexin, a novel Annexin V homodimer, provides prolonged microvascular protection against warm hepatic ischemia-reperfusion injury in mice. Gastroenterology 133:632-646.
11. Thery C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2:569-579.
12. Morel O, Toti F, Hugel B, Freyssinet J-M (2004) Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 11:156-164.
13. Piccin A, Murphy WG, Smith OP (2007) Circulating microparticles: pathophysiology and clinical implications. Blood Rev 21:157-171.
14. Mallat Z, Hugel B, Ohan J, Lesèche G, Freyssinet JM, et al (1999) Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenecity. Circulation 99:348-353.
15. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, et al (2001) Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104:2649-2652.
16. Sabatier F, Roux V, Anfosso F, Camoin L, Sampol J, et al (2002) Interaction of microparticles with monocytic cells in vitro induces tissue factor dependent procoagulant activity. Blood 99:3962-3970.
17. Albano E (2007) Seek and hide phosphatidylserine: a new approach to prevent hepatic ischemia/reperfusion injury. Gastroenterology 133:713-716.
18. Rautou PE, Bresson J, Sainte-Marie Y, Vion AC, Paradis V, et al (2012) Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis. Gastroenterology 143:166-176.
19. Kornek M, Popov Y, Libermann TA, Afdhal NH, Schuppan DS (2011) Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells. Hepatology 53:230-242.
20. Tsai I, Croft KD, Mori TA, Falck JR, Beilin LJ, et al (2009) 20-HETE and F2-isoprostanes in the metabolic syndrome. Free Rad Biology Med 46:263-270.
21. Proudfoot JM, Barden AE, Loke WM, Croft KD, Mori TA (2009) HDL is the major lipoprotein carrier of plasma F2-isoprostanes. J Lipid Research 50:716-722.
22. Jy W, Horstman LL, Jimenez JJ, Ahn YS (2004) Measuring circulating cell-derived microparticles. J Thromb Hemostasis 2:1842-1851.
23. Han MS, Park SY, Shinzawa K, Kim S, Chung KW, et al (2008) Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes. J Lipid Research 49:84-97.
24. Fourcade O, Simon M-F, Viode C, Rugani N, Leballe F, et al (1995) Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80:919-927.
25. Barry OP, Pratico D, Lawson JA, Fitzgerald GA (1997) Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest99:2118-2127.
26. van Velzen JF, Laros-van Gorkom BA, Pop GA, van Heerde WL (2012) Multicolor flow cytometry for evaluation of platelet surface antigens and acitvation markers. Thromb Res 2012;130:92-98.
27. Heuser JE, Anderson RG (1989) Hypertonic media inhibit receptor mediated endocytosis by blocking clathrin-coated pit formation. J Cell Biol 108:389-400.
28. Pasquet JM, Dachary-Pringent J, Nurden AT (1996) Calcium influx is a determining factor of calpain activation and microparticle formation in platelets. Eur J Biochem 239:647-654.
29. Combes V, Coltel N, Faille D, Wassmer SC, Grau GE (2006) Cerebral malaria: role of microparticles and platelets in alterations of the blood-brain barrier. Int J Parasitol 36:541-456.
30. Uehara T, Bennett B, Sakata ST, Satoh Y, Bilter GK, et al (2005) JNK mediates hepatic ischemia reperfusion injury. J Hepatol 42:850-859.
31. Yano Y, Shiba E, Kambayashi J, Sakon M, Kawasaki T, et al (1993) The effects of calpeptin on agonist induced microparticle formation from the platelet plasma membrane. Thromb Res 71:385-96.
32. Dillon SR, Mancini M, Rosen A, Schlissel MS (2000) Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation. J Immunol 164:1322-1332.
33. Rand ML, Wang H, Luthero FG, Stafford AR, Ni R, et al (2012) Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet-mediated events during thrombus formation. J Thromb Haemost 10:1109-1119.